Clinical Trial Update: Oral Testosterone for Fatigue in Male Multiple Sclerosis Patients [Phase 2]

View source ↗

Summary

Phase 2 trial of oral testosterone for fatigue in male multiple sclerosis patients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Oral Testosterone (testosterone)

Snippet

Sponsor: Health Sciences Centre, Winnipeg, Manitoba | Conditions: Multiple Sclerosis, Fatigue | Phase 2 | Status: TERMINATED